These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 8942335

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K.
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [Abstract] [Full Text] [Related]

  • 3. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M, Mowafi H, al-Ghamdi A, el-Sanabary M.
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
    Stevens JB, Walker SC, Fontenot JP.
    Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M, Vilardi V, Fierro G, Rosa G, Pelaia P, Gasparetto A.
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE, Donati F, Bevan DR.
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [Abstract] [Full Text] [Related]

  • 13. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW.
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [Abstract] [Full Text] [Related]

  • 14. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM, McChristian JW, Miller RD, Taboada JA, Cronnelly R.
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [Abstract] [Full Text] [Related]

  • 15. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
    Barrio J, San Miguel G, García V, Pelegrín F.
    Rev Esp Anestesiol Reanim; 2007 Jun; 54(7):399-404. PubMed ID: 17953333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Spontaneous or neostigmine-induced recovery after maintenance of neuromuscular block with Org 9487 (rapacuronium) or rocuronium following an initial dose of Org 9487.
    McCourt KC, Mirakhur RK, Lowry DW, Carroll MT, Sparr HJ.
    Br J Anaesth; 1999 May; 82(5):755-6. PubMed ID: 10536556
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reversal of doxacurium and pancuronium neuromuscular blockade with neostigmine in children.
    Bevan JC, Purday JP, Reimer EJ, Bevan DR.
    Can J Anaesth; 1994 Nov; 41(11):1074-80. PubMed ID: 7828255
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.